TREPROSTINIL for Ventricular septal defect: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where TREPROSTINIL was used for Ventricular septal defect.
Most Reported Side Effects for TREPROSTINIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 16,348 | 17.8% | 1,268 | 8,371 |
| Headache | 14,051 | 15.3% | 369 | 3,789 |
| Diarrhoea | 11,335 | 12.4% | 447 | 3,744 |
| Nausea | 10,320 | 11.2% | 420 | 3,509 |
| Cough | 8,945 | 9.7% | 293 | 2,282 |
| Fatigue | 7,440 | 8.1% | 302 | 2,328 |
| Dizziness | 7,405 | 8.1% | 244 | 2,388 |
| Infusion site pain | 5,169 | 5.6% | 114 | 1,292 |
| Vomiting | 5,097 | 5.6% | 236 | 2,181 |
| Death | 4,764 | 5.2% | 4,761 | 1,821 |
| Hypotension | 4,412 | 4.8% | 469 | 2,437 |
| Malaise | 4,410 | 4.8% | 282 | 1,626 |
| Pain in extremity | 4,138 | 4.5% | 142 | 1,331 |
| Oxygen saturation decreased | 3,865 | 4.2% | 375 | 2,079 |
| Pneumonia | 3,814 | 4.2% | 482 | 3,328 |
Other Indications for TREPROSTINIL
Pulmonary arterial hypertension (72,609)
Pulmonary hypertension (10,034)
Product used for unknown indication (7,658)
Cor pulmonale chronic (1,407)
Interstitial lung disease (251)
Lung disorder (173)
Pulmonary fibrosis (171)
Hypoxia (164)
Idiopathic pulmonary fibrosis (127)
Connective tissue disorder (109)